Related references
Note: Only part of the references are listed.Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes-A Report From the Children's Oncology Group
Javier G. Blanco et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cardiovascular Disease Cause of Morbidity and Mortality in Adult Survivors of Childhood Cancers
Ming Hui Chen et al.
CIRCULATION RESEARCH (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
The Vulnerability of the Heart As a Pluricellular Paracrine Organ Lessons From Unexpected Triggers of Heart Failure in Targeted ErbB2 Anticancer Therapy
Gilles W. De Keulenaer et al.
CIRCULATION RESEARCH (2010)
Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma
T. Nousiainen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Long-Term Cardiac Follow-Up of Children Treated With Anthracycline Doses of 300 mg/m2 or Less for Acute Lymphoblastic Leukemia
Mathias Rathe et al.
PEDIATRIC BLOOD & CANCER (2010)
Can Anthracycline Therapy for Pediatric Malignancies Be Less Cardiotoxic?
Joy M. Fulbright et al.
CURRENT ONCOLOGY REPORTS (2010)
Pharmacological Foundations of Cardio-Oncology
Giorgio Minotti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor Study
Gregory T. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Doxorubicinolone Formation and Efflux: A Salvage Pathway against Epirubicin Accumulation in Human Heart
Emanuela Salvatorelli et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Cardiovascular Complications of Cancer Therapy Incidence, Pathogenesis, Diagnosis, and Management
Edward T. H. Yeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Utility of Tissue Doppler and Strain Rate Imaging in the Early Detection of Trastuzumab and Anthracycline Mediated Cardiomyopathy
Davinder S. Jassal et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2009)
Increased Risk of Stroke and Transient Ischemic Attack in 5-Year Survivors of Hodgkin Lymphoma
Marie L. De Bruin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Cardiovascular toxicity caused by cancer treatment: strategies for early detection
Renske Altena et al.
LANCET ONCOLOGY (2009)
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort
Daniel A. Mulrooney et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:Quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
Javier G. Blanco et al.
CANCER (2008)
Anthracycline cardiotoxicity: From bench to bedside
Luca Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the cardiovascular disease task force of the children's oncology group
Sadhna M. Shankar et al.
PEDIATRICS (2008)
Late effects of thoracic irradiation in children
Tobias Boelling et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2008)
Detection and monitoring of cardiotoxicity - what does modern cardiology offer?
Ruxandra Jurcut et al.
SUPPORTIVE CARE IN CANCER (2008)
Anthracycline associated cardiotoxicity in survivors of childhood cancer
Steven E. Lipshultz et al.
HEART (2008)
Early breast cancer therapy and cardiovascular injury
Lee W. Jones et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management
Elly Barry et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Dexrazoxane-Associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease
Cameron K. Tebbi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Molecular and cellular mechanisms of anthracycline cardiotoxicity
Billy Chen et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Role of mtDNA lesions in anthracycline cardiotoxicity
Dirk Lebrecht et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Genotyping the risk of anthracycline-induced cardiotoxicity
Shiwei Deng et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Cardiovascular risk reduction in high-risk pediatric patients - A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research
Rae-Ellen W. Kavey et al.
CIRCULATION (2006)
Thiopurine S-methyltransferase pharmacogenetics:: insights, challenges and future directions
L Wang et al.
ONCOGENE (2006)
Pathophysiology of anthracycline- and radiation-associated card iomyopathies: Implications for screening and prevention
MJ Adams et al.
PEDIATRIC BLOOD & CANCER (2005)
Pathology of radiation and anthracycline cardiotoxicity
GJ Berry et al.
PEDIATRIC BLOOD & CANCER (2005)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults
O Hequet et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Cardiac safety of pegylated liposomal doxorubicin (Doxil((R))/Caelyx((R))) demonstrated by endomyocardial biopsy in patients with advanced malignancies
AA Gabizon et al.
CANCER INVESTIGATION (2004)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Doxorubicin cardiotoxicity: Prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era
I Mitani et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2003)
Radiation-associated cardiovascular disease
MJ Adams et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
The clinical value of nuclear medicine in the assessment of irradiation-induced and anthracycline-associated cardiac damage
I Goethals et al.
ANNALS OF ONCOLOGY (2002)
Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children:: a systematic review
LCM Kremer et al.
ANNALS OF ONCOLOGY (2002)
The final common pathway hypothesis and inherited cardiovascular disease - The role of cytoskeletal proteins in dilated cardiomyopathy
NE Bowles et al.
HERZ (2000)
Share Paper
